hat
Etid klinik nan megestrol asetat poud nan tretman an nan anorexia, kachaksi, oswa yon pèt siyifikatif pwa siyifikatif nan pasyan ki gen SIDA pa t 'gen ladan nimewo ase nan pasyan ki gen laj 65 ane ak pi gran yo detèmine si yo reponn yon fason diferan pase pasyan ki pi piti. Lòt eksperyans nan klinik rapòte pa idantifye diferans ki genyen nan repons ant pasyan granmoun aje ak pi piti. An jeneral, seleksyon dòz pou yon pasyan granmoun aje yo ta dwe pridan, anjeneral kòmanse nan fen ki ba nan ranje a dòz, reflete frekans nan pi gwo nan diminye epis, ren, oswa kadyak fonksyon, ak nan maladi konmidan oswa lòt terapi dwòg.
eng
Clinical studies of Megestrol acetate powder in the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with AIDS did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently than younger patients. Other reported clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.